Healthcare -
Biotechnology - NASDAQ - CH
$ 1.845
0.272 %
$ 4.56 M
Market Cap
-0.27
P/E
NLSP - COST OF REVENUE
Cost of Revenue NLSP - NLS Pharmaceutics AG
11.4 K
LAST VALUE
6.54%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR